L-DABA

Overview

L-DABA (L-2,4-Diaminobutyric acid) is a week GABA transaminase inhibitor with an IC 50 of larger than 500 μM; exhibits antitumor activity in vivo and in vitro .

Application

Products | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurodegenerative Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > GABA Receptor | Products > Signaling Pathways > Endogenous Metabolite

Product Information

• Catalog No.: HY-101414
• CAS No.: 1758-80-1
• Molecular Formula: C4H10N2O2
• Molecular Weight: 118.13
• Purity: 99.93%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 100 mg/mL (846.53 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source